Gattex

Active Ingredient(s): Teduglutide
FDA Approved: * December 21, 2012
Pharm Company: * NPS PHARMACEUTICALS, INC.

Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome. It works by promoting mucosal growth and possibly restoring gastric emptying and secretion.[1] In Europe it has been granted orphan drug status and is marketed under the brand Revestive by Nycomed. It was approved by the United States under the name Gattex on 21 December 2012 and also... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Gattex 5 mg/1 Subcutaneous Injection, Powder, for Solution

NDC: 68875-0101

Labeler:

Nps Pharmaceuticals

Gattex Kit

NDC: 68875-0102

Labeler:

Nps Pharmaceuticals

Gattex Kit

NDC: 68875-0103

Labeler:

Nps Pharmaceuticals

Dosage List

Popular Topics